These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 10572161)

  • 21. Provision of home dialysis by freestanding renal dialysis facilities.
    Kendix M
    Health Care Financ Rev; 1995; 17(2):105-22. PubMed ID: 10157371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of U.S. Dialysis facility neighborhood characteristics with facility-level kidney transplantation.
    Plantinga L; Pastan S; Kramer M; McClellan A; Krisher J; Patzer RE
    Am J Nephrol; 2014; 40(2):164-73. PubMed ID: 25196018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between Freestanding Dialysis Facility Size and Medicare Quality Incentive Program Performance Scores.
    Ajmal F; Probst J; Brooks J; Hardin J; Qureshi Z
    Am J Nephrol; 2019; 49(1):64-73. PubMed ID: 30557871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors affecting the availability and use of hemodialysis facilities.
    Cleary PD; Schlesinger M; Blumenthal D
    Health Care Financ Rev; 1991; 13(2):49-55. PubMed ID: 10122361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Racial differences in access to kidney transplantation.
    Eggers PW
    Health Care Financ Rev; 1995; 17(2):89-103. PubMed ID: 10157383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Holiday dialysis.
    Smith K
    Nurs Stand; 2003 Aug 13-19; 17(48):18-9. PubMed ID: 14515534
    [No Abstract]   [Full Text] [Related]  

  • 27. Medicare Enrollment Among Patients With End-Stage Kidney Disease Receiving Dialysis in Outpatient Facilities Between 2005 and 2016.
    Hoffman A; Sloan CE; Maciejewski ML; Wang V
    JAMA; 2020 Apr; 323(13):1314-1316. PubMed ID: 32259222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Access to Kidney Transplantation: Is There a Potential Conflict of Interest?
    Rubin MF; Weir MR
    Am J Nephrol; 2015; 41(6):502-3. PubMed ID: 26278422
    [No Abstract]   [Full Text] [Related]  

  • 29. Differences in health-related quality of life and treatment preferences among black and white patients with end-stage renal disease.
    Hicks LS; Cleary PD; Epstein AM; Ayanian JZ
    Qual Life Res; 2004 Aug; 13(6):1129-37. PubMed ID: 15287279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gridlock on the road to kidney transplantation.
    Chertow G; Zenios S
    Am J Kidney Dis; 2001 Feb; 37(2):435-7. PubMed ID: 11157389
    [No Abstract]   [Full Text] [Related]  

  • 31. The production of dialysis by for-profit versus not-for-profit freestanding renal dialysis facilities.
    Griffiths RI; Powe NR; Gaskin DJ; Anderson GF; de Lissovoy GV; Whelton PK
    Health Serv Res; 1994 Oct; 29(4):473-87. PubMed ID: 7928373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dialysis facility ownership and epoetin dosing in patients receiving hemodialysis.
    Thamer M; Zhang Y; Kaufman J; Cotter D; Dong F; Hernán MA
    JAMA; 2007 Apr; 297(15):1667-74. PubMed ID: 17440144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The for-profit providers.
    Bander SJ; Hakim R; Lazarus MJ; Lindenfeld S
    Nephrol News Issues; 2000 Feb; 14(3):13-5. PubMed ID: 11933347
    [No Abstract]   [Full Text] [Related]  

  • 34. Possible effects of the new Medicare reimbursement policy on African Americans with ESRD.
    Ishani A; Guo H; Arneson TJ; Gilbertson DT; Mau LW; Li S; Dunning S; Collins AJ
    J Am Soc Nephrol; 2009 Jul; 20(7):1607-13. PubMed ID: 19389846
    [No Abstract]   [Full Text] [Related]  

  • 35. Institutionalized racism and end-stage renal disease: is its impact real or illusionary?
    Callender CO; Miles PV
    Semin Dial; 2004; 17(3):177-80. PubMed ID: 15144537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Freestanding Dialysis Facility Quality Incentive Program Scores and Mortality Among Incident Dialysis Patients in the United States.
    Ajmal F; Probst JC; Brooks JM; Hardin JW; Qureshi Z; Jafar TH
    Am J Kidney Dis; 2020 Feb; 75(2):177-186. PubMed ID: 31685294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival of patients undergoing renal replacement therapy in one center with special emphasis on racial differences.
    Bleyer AJ; Tell GS; Evans GW; Ettinger WH; Burkart JM
    Am J Kidney Dis; 1996 Jul; 28(1):72-81. PubMed ID: 8712225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal transplantation in black Americans.
    Young CJ; Gaston RS
    N Engl J Med; 2000 Nov; 343(21):1545-52. PubMed ID: 11087885
    [No Abstract]   [Full Text] [Related]  

  • 39. Relationship between patients' perceptions of disadvantage and discrimination and listing for kidney transplantation.
    Klassen AC; Hall AG; Saksvig B; Curbow B; Klassen DK
    Am J Public Health; 2002 May; 92(5):811-7. PubMed ID: 11988452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Access to renal transplantation among American Indians and Hispanics.
    Sequist TD; Narva AS; Stiles SK; Karp SK; Cass A; Ayanian JZ
    Am J Kidney Dis; 2004 Aug; 44(2):344-52. PubMed ID: 15264194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.